Home » Stocks » MYMD

MyMD Pharmaceuticals, Inc. (MYMD)

Stock Price: $3.39 USD -0.25 (-6.87%)
Updated May 14, 2021 4:00 PM EDT - Market closed
Market Cap 130.92M
Revenue (ttm) n/a
Net Income (ttm) -17.58M
Shares Out 3.53M
EPS (ttm) -4.98
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 14
Last Price $3.39
Previous Close $3.64
Change ($) -0.25
Change (%) -6.87%
Day's Open 3.61
Day's Range 3.35 - 3.72
Day's Volume 151,239
52-Week Range 1.65 - 7.89

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

BALTIMORE--(BUSINESS WIRE)--MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms...

2 weeks ago - Business Wire

BALTIMORE--(BUSINESS WIRE)--MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms...

3 weeks ago - Business Wire

MyMD Pharmaceuticals (MYMD) stock is among the biggest movers today with shares soaring just one day after the company's IPO. The post MyMD Pharmaceuticals IPO: 10 Things for MYMD Stock Investors to Kno...

3 weeks ago - InvestorPlace

BALTIMORE--(BUSINESS WIRE)--Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger

Other stocks mentioned: AKER
4 weeks ago - Business Wire

BALTIMORE--(BUSINESS WIRE)--Akers Biosciences, Inc. (NASDAQ: AKER), today announced that its proposed merger partner MyMD Pharmaceuticals, Inc. (“MyMD”), a clinical stage pharmaceutical company committe...

Other stocks mentioned: AKER
1 month ago - Business Wire

BALTIMORE--(BUSINESS WIRE)--Akers Biosciences, Inc. (Nasdaq: AKER), today announced that its proposed merger partner MyMD Pharmaceuticals, Inc. (“MyMD”), a clinical stage pharmaceutical company committe...

Other stocks mentioned: AKER
1 month ago - Business Wire

BALTIMORE & THOROFARE, N.J.--(BUSINESS WIRE)--Akers Biosciences, Inc (Nasdaq: AKER), today announced that it has scheduled its general meeting of shareholders (the "Meeting”) to vote on the proposed bus...

Other stocks mentioned: AKER
1 month ago - Business Wire

NEW YORK, March 12, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights o...

Other stocks mentioned: AKER, CBLI, TLRY
2 months ago - PRNewsWire

Akers Biosciences Inc (NASDAQ: AKER) and its proposed merger partner MyMD Pharmaceuticals Inc have announced new data for MYMD-1 from the Eurofins Discovery Phenotypic Center of Excellence study. MYMD-1...

Other stocks mentioned: AKER
2 months ago - Benzinga

BALTIMORE--(BUSINESS WIRE)--Akers Biosciences, Inc. (Nasdaq: AKER), with its proposed merger partner MyMD Pharmaceuticals, Inc. (“MyMD”), a clinical stage pharmaceutical company committed to extending h...

Other stocks mentioned: AKER
2 months ago - Business Wire

BALTIMORE--(BUSINESS WIRE)--Akers Biosciences, Inc. (Nasdaq: AKER), with its proposed merger partner MyMD Pharmaceuticals, Inc. (“MyMD”), a clinical stage pharmaceutical company committed to extending h...

Other stocks mentioned: AKER
2 months ago - Business Wire

NEW YORK--(BUSINESS WIRE)--Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER) confirmed that a press release issued earlier today with respect to an earnings call by Aker ASA was issued by a company...

Other stocks mentioned: AKER
2 months ago - Business Wire

NEW YORK, Dec. 19, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Akers Biosciences, Inc. (NASDAQ: AKER) concerning pote...

Other stocks mentioned: AKER
4 months ago - PRNewsWire

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Akers Bioscience...

Other stocks mentioned: AKER
5 months ago - Business Wire

BALTIMORE--(BUSINESS WIRE)--Akers Biosciences, Inc. (Nasdaq: AKER), today announced that its proposed merger partner MyMD Pharmaceuticals, Inc. (“MyMD”) was issued US Pat. No. 10,835,523 B2, titled “Met...

Other stocks mentioned: AKER
5 months ago - Business Wire

NEW YORK, Nov. 18, 2020 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York Cit...

Other stocks mentioned: AKER
5 months ago - PRNewsWire

BALTIMORE--(BUSINESS WIRE)--MyMD Pharmaceuticals, Inc. ("MyMD") and Akers Biosciences, Inc. ("Akers") (NASDAQ: AKER) jointly announced a definitive merger agreement last week. The companies plan to hold...

Other stocks mentioned: AKER
5 months ago - Business Wire

BERWYN, Pa., Nov. 17, 2020 /PRNewswire/ -- RM LAW, P.C. is investigating potential claims against the board of directors of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) regarding po...

Other stocks mentioned: AKER
5 months ago - PRNewsWire

NEW YORK, Nov. 12, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Akers Biosciences, Inc. ("Akers" or the...

Other stocks mentioned: AKER
6 months ago - PRNewsWire

NEW YORK, Nov. 12, 2020 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Akers Biosciences, Inc. (NASDAQ: AKER) and its board of directors concerning the proposed ...

Other stocks mentioned: AKER
6 months ago - PRNewsWire

BALTIMORE & THOROFARE, N.J.--(BUSINESS WIRE)--MyMD Pharmaceuticals, Inc. (“MyMD”) and Akers Biosciences, Inc. (“Akers”) (NASDAQ: AKER) today jointly announced that they have entered into a definitive me...

Other stocks mentioned: AKER
6 months ago - Business Wire

Thorofare, New Jersey, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced with its partner,...

Other stocks mentioned: AKER
8 months ago - GlobeNewsWire

Thorofare, New Jersey, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), today announced that it has entered into definitive agreements with several institution...

Other stocks mentioned: AKER
9 months ago - GlobeNewsWire

Company intends to cease focus on screening and testing products business

Other stocks mentioned: AKER
10 months ago - GlobeNewsWire

Thorofare, New Jersey, May 18, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced the closing of its...

Other stocks mentioned: AKER
11 months ago - GlobeNewsWire

Thorofare, New Jersey, May 14, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that it has entere...

Other stocks mentioned: AKER
1 year ago - GlobeNewsWire

Thorofare, New Jersey, May 14, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that Premas Biotec...

Other stocks mentioned: AKER
1 year ago - GlobeNewsWire

Akers Biosciences Jumps On COVID-19 Vaccine Progress, Will Remain Volatile

Other stocks mentioned: AKER
1 year ago - Seeking Alpha

Thorofare, New Jersey, April 08, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that its collabo...

Other stocks mentioned: AKER
1 year ago - GlobeNewsWire

Thorofare, New Jersey, April 07, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that it has ente...

Other stocks mentioned: AKER
1 year ago - GlobeNewsWire

Akers Biosciences Inc (NASDAQ: AKER) shares gap-opened higher Monday and were trading with handsome gains.

Other stocks mentioned: AKER
1 year ago - Benzinga

Thorofare, New Jersey, April 06, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that its collabo...

Other stocks mentioned: AKER
1 year ago - GlobeNewsWire

Thorofare, New Jersey, March 24, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that it has acqu...

Other stocks mentioned: AKER
1 year ago - GlobeNewsWire

Thorofare, New Jersey, Jan. 17, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that it reached a...

Other stocks mentioned: AKER
1 year ago - GlobeNewsWire

Thorofare, New Jersey, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, announced today that on December ...

Other stocks mentioned: AKER
1 year ago - GlobeNewsWire

Thorofare, New Jersey, Dec. 09, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company” or “we”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced the closi...

Other stocks mentioned: AKER
1 year ago - GlobeNewsWire

Thorofare, New Jersey, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that Executive Ch...

Other stocks mentioned: AKER
1 year ago - GlobeNewsWire

Thorofare, New Jersey, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company” or “we”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced the prici...

Other stocks mentioned: AKER
1 year ago - GlobeNewsWire

· Establishes Advisory Board appointing Bob Hoban and Michael Patterson

Other stocks mentioned: AKER
1 year ago - GlobeNewsWire

THOROFARE, N.J., Nov. 22, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, today announced that ef...

Other stocks mentioned: AKER
1 year ago - GlobeNewsWire

About MYMD

MyMD Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the development of drug products in the targeting of aging and age-related diseases; autoimmune diseases; and chronic pain, anxiety, and sleep disorders. It commercializes MYMD-1, a novel therapeutic to impact conditions related to immunometabolic dysregulation; and SUPERA-1R, a synthetic cannabidiol that offers bioavailability and potency than botanicals. The company was incorporated in 2014 and is based in Tampa, Florida.

Industry
Biotechnology
Founded
2014
CEO
Howard Yeaton
Employees
6
Stock Exchange
NASDAQ
Ticker Symbol
MYMD
Full Company Profile

Financial Performance

Financial Statements